AddictionRecovery

Purdue Pharma Proposes New Chapter 11 Plan Amid Ongoing Bankruptcy Negotiations

1 month ago

Purdue Pharma, the controversial pharmaceutical company known for its role in the opioid crisis, has submitted a revised Chapter 11 reorganization plan as part of its bankruptcy proceedings. This significant move comes as the company seeks to navigate the challenging waters of its financial and ethical responsibilities stemming from its past practices related to the sale of OxyContin. The new proposal aims to satisfy numerous stakeholders in a complex legal landscape marked by extensive claims from various states, municipalities, and individuals affected by opioid addiction.

Purdue Pharma Proposes $7 Billion Settlement in Opioid Lawsuit, Involving Sackler Family Contributions

1 month ago

Purdue Pharma, the pharmaceutical company at the center of the opioid crisis in the United States, has put forth a detailed plan to address lawsuits filed against it by various states and municipalities. The proposal includes an unprecedented commitment of up to $7 billion from the Sackler family, the owners of Purdue Pharma. This significant move is aimed at resolving thousands of legal claims tied to the widespread addiction crisis that has devastated countless families and communities across the country.

Purdue Pharma and Sackler Family Conclude Historic $7.4 Billion Opioid Settlement

3 months ago

In a landmark development regarding the ongoing opioid crisis in the United States, Purdue Pharma, the maker of the highly controversial painkiller OxyContin, along with the Sackler family, has agreed to a staggering $7.4 billion settlement. This settlement is aimed at resolving claims from thousands of individuals and municipalities affected by the opioid epidemic, further adding to the extensive legal battles the company has been embroiled in.

The Race Against Time: Can a Fentanyl Vaccine Curb the Opioid Crisis?

6 months ago

In a groundbreaking development in the fight against the escalating opioid epidemic in the United States, researchers are optimistic about the potential of a novel fentanyl vaccine. This innovative approach could revolutionize addiction treatment and significantly reduce the staggering number of overdose deaths attributed to this powerful synthetic opioid, which has claimed thousands of lives each year.